Jinfo BlogA "Survival Kit" for Biopharma CI Professionals

Tuesday, 24th June 2014 Sign in to MyJinfo or create an account be able to star items Click for printable version Subscribe via RSS to get updates as soon as Blog items are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn

By Yulia Aspinall

« Blog

Abstract

Start-up biotechs and small pharma companies may not be able to afford access to expensive resources for competitive intelligence. Yulia Aspinall examines how to provide an essential CI service on a low budget.

Item

Competitive Intelligence (CI) professionals in the biopharmaceutical industry are under constant pressure to provide timely, current and reliable intelligence on competitors.

Although there are vast resources available to capture human and published intelligence, access can be expensive.

A CI Service on a Shoestring

For start-up biotechs or small pharma companies, such expenditure is likely to be a relatively low priority, but arguably understanding the competitive environment is especially important for these types of organisations.

Here are a few tips on how to provide an essential CI service, even with limited or no budget:

  • To collect human or primary intelligence, use internal sources - up to 80% of vital intelligence can be collected inside the company. Knowing your customers well can provide a double benefit - so understand what knowledge on competitors is held internally and where are the gaps

  • To collect free published information, use reliable resources such as PubMed for biomedical, ClinicalTrials.gov for clinical, EMA for regulatory, EPO for patent, and Consumer Reports
  • For analysis, websites such as AuthorMapper, GoPubMed and Tableau Public can be useful

  • For reporting you may want to consider Prezi or ThinkStoryline approach.

And, of course, don't forget about your own personal development (SCIP) and keeping in touch with your CI colleagues (LinkedIn)!

Editor's Note

FreePint Subscribers can log in to read and share more in Yulia Aspinall's article, Pharma Perspectives on CI Trends.

This article is part of the FreePint Topic Series: Next-Generation Competitive Intelligence running from May-June 2014. Register your interest now, and you'll also get a free copy of the FreePint Report: Buyer's Guide on Competitive Intelligence when it's published in June.

« Blog

Benefit from our research

Content and Community

Claire Laybats, Head of Commercial DevelopmentConnect your team with the practical tools, original research and expertise to build and support information strategy in your organisation.

A Jinfo Subscription gives access to all Content (articles, reports, webinars) and Community.

Subscription benefits


Consulting

Robin Neidorf, Head of ConsultingOur proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.

Read case studies, and start the conversation.

Consulting benefits